What is the Nanollose (ASX: NC6) share price?
The NC6 share price is $0.05, down 1.96% for the day, based on the latest available ASX market data.
What is Nanollose's market capitalisation?
Nanollose has a market capitalisation of $17.5M, making it the 1331st-largest security listed on the ASX.
Does Nanollose pay a dividend?
NC6 does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Nanollose profitable?
In its most recent reported period (ending 31 Dec 2025), NC6 reported revenue of $0 and a net loss of $1.5M.
How many NC6 shares are on issue?
Nanollose has approximately 350,963,580 shares on issue, based on its market capitalisation of $17.5M and current share price.
What sector is Nanollose in?
Nanollose is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Nanollose list on the ASX?
Nanollose listed on the Australian Securities Exchange on 17 Oct 2017.
